NEW YORK (GenomeWeb News) – Pressure BioSciences today reported that its second-quarter 2009 revenues more than doubled year over year, while the firm trimmed its net loss in half.

The South Easton, Mass.-based firm brought in revenues of $270,381 for the three-month period ended June 30, compared to $120,184 for the second quarter of 2008. Sales of its pressure cycling technology products and services rose 35 percent to $159,202 from $117,698.

The company cut its net loss in half to $814,049, or $.39 per share, from $$1.6 million, or $.72 per share.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: caution urged in use of gene drives, and more.

NIH's Sally Rockey examines the tapped and untapped potential of the NIH peer reviewer pool.

PLOS Biology has asked researchers how they envision the future of genetics and genomics.

Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."